Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
Highlights the limitations of using aPTT for monitoring argatroban therapy and suggests considering drug-calibrated specific assays.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Veen et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: